Status:
WITHDRAWN
Tobradex BID Compared to TOBRADEX and TOBREX/Vehicle
Lead Sponsor:
Alcon Research
Conditions:
Post-surgical Inflammation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the new formulation of Tobradex to the current approved formulation
Eligibility Criteria
Inclusion
- Patients scheduled for cataract extraction
Exclusion
- Under 18 years
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00404937
Start Date
December 1 2006
End Date
December 1 2006
Last Update
March 6 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.